Genenta Science S.p.A.
GNTAIndustrialsNASDAQConglomerates · Last scanned Sep 8, 2026
Scan Results
Daily timeframePart of the industrials sector, Genenta Science S.p.A. (GNTA) is listed under Conglomerates. The $46.3M market capitalization puts GNTA squarely in micro-cap range for its industry. Its activities and acquisition strategy span aerospace, defense, national security (including cybersecurity), and biotechnology/biosecurity.
Market Cap
$46.3M
Beta
0.72
P/E (TTM)
—
P/E (Fwd)
-1.48
EPS (TTM)
$-0.38
EPS (Fwd)
$-0.65
ROE
-38.0%
ROA
-17.7%
Cash
$28.1M
Total Debt
$7.6M
Free CF
-$3.1M
52W Change
-71.9%
Annual Financials
Cash vs Debt
Where GNTA stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, GNTA finished 10.91% below its 150-day moving average ($1.10) and 19.67% below its 200-day moving average ($1.22). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is GNTA overbought or oversold?
At the September 3, 2026 close, GNTA's RSI(14) was 24.0, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Genenta Science S.p.A. holds $28.1M in cash against $7.6M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow is running at -$3.1M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -38.0%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing GNTA's risk profile alongside its fundamentals and technical indicators provides a more complete picture.